Skip to main content

Table 4 Retrospective analysis of 232 lung adenocarcinoma patients by five binary classifiers. There were 80 patients in the control and 152 patients in the treatment

From: Subgroup identification for treatment selection in biomarker adaptive design

  DLDA ASD (−0.5,1) ASD (−0.5,2) ASD (−1,1) ASD (−1,2)
Comparison 1 0.014 0.014 0.014 0.014 0.014
Comparison 4 0.018 0.049 0.014 NA NA
Comparison 5 0.86 0.024 NA NA NA
Comparison 2 0.578 0.739 NA NA NA
Comparison 3 0.432 0.061 0.024 0.014 0.014
g+ (T) 3.40 (55)a 2.95 (118) 2.80 (146) 1.84 (152) 1.84 (152)
g+ (C) 2.36 (97) 1.98 (34) 1.16 (6) NA (0) NA (0)
g− (T) 3.82 (73) 3.89 (75) 3.46 (80) 3.46 (80) 3.46 (80)
g− (C) 3.35 (7) 2.02 (5) NA (0) NA (0) NA (0)
  1. aMedian survival time (year) in the subgroup and the number of patients in the subgroup in parentheses